Vitamin D3 for Heart Health in Parkinson's Men
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether taking vitamin D3 supplements can improve the nerve function that controls your heartbeat in men with Parkinson's disease who have low vitamin D levels. If you have mild to moderate Parkinson's and are on levodopa, this trial may help understand if vitamin D can support your heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 51 and 70 years old
- You have Parkinson's disease with mild to moderate movement problems
- Your body mass index (BMI) is between 18.5 and 24.9 (normal weight range)
- Your vitamin D levels are low (deficient or insufficient)
- You are currently taking levodopa medication for Parkinson's
- You are not taking certain other medications like blood pressure pills, statins, or vitamin supplements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different amounts of physical exercise affect brain chemicals, movement symptoms, and brain connections in people with Parkinson's disease. You would walk and do exercises while researchers track changes over time.
This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.
This study looks at whether physical activity can reduce inflammation in the brain for people with Parkinson's disease. It aims to understand how exercise might help slow the progression of the disease.
This trial tests whether a strength training program can improve function and body chemistry in people with Parkinson's. It may help if you are in the middle stages of the disease and have stable motor symptoms.
This trial studies whether a physical activity program can improve brain health and thinking skills in people with Parkinson's disease who also have mild cognitive impairment. It is designed for those who are not already very active.
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.